About

Thomas Seisen is a leading urologic oncologist whose research centers on optimizing surgical outcomes for kidney, bladder, and upper tract cancers. His landmark study comparing 1,800 robotic and open partial nephrectomies (179 citations) provided crucial evidence on the safety and efficacy of minimally invasive surgery for renal tumors. Seisen has been instrumental in advancing robotic techniques, authoring a pivotal European Association of Urology guidelines systematic review on laparoscopic versus open nephroureterectomy for upper tract urothelial carcinoma (156 citations). His work on radical cystectomy costs (83 citations) and comparative effectiveness of robot-assisted versus open cystectomy (75 citations) has informed both clinical practice and healthcare policy. Through multi-institutional studies, Seisen demonstrated how hospital and surgeon volume impact robotic partial nephrectomy outcomes (63 citations), establishing quality benchmarks. His prospective multicenter research on long-term oncological outcomes after robotic partial nephrectomy (31 citations) and off-clamp techniques (23 citations) has refined surgical approaches. With over 600 total citations, Seisen’s contributions have shaped modern urologic oncology, particularly in demonstrating that robotic surgery can achieve oncologic equivalence to open approaches while reducing morbidity.

Research Focus

Key Achievements

15
H-Index
35
Papers
940
Total Citations
27
Avg Citations/Paper
🏆 Most Cited Paper
Comparison of 1800 Robotic and Open Partial Nephrectomies for Renal Tumors
179 citations · 2016
📈 Most Prolific Year: 2017 (6 Papers)
🤝 Key Collaborators: 140
🏛 Institutions: Sorbonne Université, Brigham and Women's Hospital, Université de Bordeaux, Assistance Publique – Hôpitaux de Paris, Pitié-Salpêtrière Hospital, Onco-Urologie Prédictive

Top Papers

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 14 days ago